BOSTON--(BUSINESS WIRE)-- AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 6,900,000 shares of its common stock, which includes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback